OBJECTIVE: This study was designed to prospectively investigate the efficacy and cognitive adverse effects of stereotactic bilateral anterior cingulotomy as a treatment for refractory obsessive-compulsive (OCD) patients for 12 months. METHOD: Patients were eligible if they had severe OCD and rigorous treatments had been unsuccessful. Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), Clinical Global Impression (CGI) and neuropsychological tests were used to assess the efficacy and cognitive changes of cingulotomy before and 12 months after operation. RESULTS: The mean improvement rate of the Y-BOCS scores achieved from baseline was 36.0%. Out of 14 patients six met responder criteria; 35% or higher improvement rate on Y-BOCS and CGI improvement of very much or much better at 12-month follow-up. There was no significant cognitive dysfunction after cingulotomy. CONCLUSION: Anterior cingulotomy shows few cognitive adverse effects, with about half of the OCD patients demonstrating significant symptomatic improvement.
OBJECTIVE: This study was designed to prospectively investigate the efficacy and cognitive adverse effects of stereotactic bilateral anterior cingulotomy as a treatment for refractory obsessive-compulsive (OCD) patients for 12 months. METHOD:Patients were eligible if they had severe OCD and rigorous treatments had been unsuccessful. Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), Clinical Global Impression (CGI) and neuropsychological tests were used to assess the efficacy and cognitive changes of cingulotomy before and 12 months after operation. RESULTS: The mean improvement rate of the Y-BOCS scores achieved from baseline was 36.0%. Out of 14 patients six met responder criteria; 35% or higher improvement rate on Y-BOCS and CGI improvement of very much or much better at 12-month follow-up. There was no significant cognitive dysfunction after cingulotomy. CONCLUSION: Anterior cingulotomy shows few cognitive adverse effects, with about half of the OCDpatients demonstrating significant symptomatic improvement.
Authors: D Huys; M Möller; E-H Kim; K Hardenacke; W Huff; J Klosterkötter; L Timmermann; C Woopen; J Kuhn Journal: Nervenarzt Date: 2012-09 Impact factor: 1.214
Authors: Negar Fani; Tricia Z King; Cherita Clendinen; Raven A Hardy; Sindhuja Surapaneni; James R Blair; Stuart F White; Abigail Powers; Tim D Ely; Tanja Jovanovic; Kerry J Ressler; Bekh Bradley Journal: J Affect Disord Date: 2019-04-30 Impact factor: 4.839
Authors: Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker Journal: BMC Psychiatry Date: 2014-07-02 Impact factor: 3.630
Authors: Theo O J Gründler; James F Cavanagh; Christina M Figueroa; Michael J Frank; John J B Allen Journal: Neuropsychologia Date: 2009-03-17 Impact factor: 3.139
Authors: Rebecca G Brenner; Christopher D Smyser; Rachel E Lean; Jeanette K Kenley; Tara A Smyser; Peppar E P Cyr; Joshua S Shimony; Deanna M Barch; Cynthia E Rogers Journal: Biol Psychiatry Date: 2020-06-27 Impact factor: 13.382